Total Payments
$1,530
2024 Payments
$49.10
Companies
18
Transactions
73
Medicare Patients
6,141
Medicare Billing
$261,187
Payment Breakdown by Category
Food & Beverage$1,276 (83.4%)
Education$254.35 (16.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,276 | 69 | 83.4% |
| Education | $254.35 | 4 | 16.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $315.62 | 15 | $0 (2023) |
| ABBVIE INC. | $226.37 | 11 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $192.98 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $149.90 | 8 | $0 (2023) |
| Lilly USA, LLC | $142.76 | 8 | $0 (2023) |
| UCB, Inc. | $129.19 | 7 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $66.87 | 1 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $49.85 | 3 | $0 (2021) |
| PFIZER INC. | $41.71 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $40.92 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.10 | 2 | PFIZER INC. ($26.44) |
| 2023 | $254.02 | 10 | Arcutis Biotherapeutics, Inc. ($66.87) |
| 2022 | $634.83 | 35 | ABBVIE INC. ($168.16) |
| 2021 | $592.08 | 26 | Regeneron Healthcare Solutions, Inc. ($136.54) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/21/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Immunology | ||||||
| 03/14/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 03/09/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Immunology | ||||||
| 03/01/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: Immunology | ||||||
| 02/06/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Dermatology | ||||||
| 02/03/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Immunology | ||||||
| 01/26/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $66.87 | General |
| 01/17/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Dermatology | ||||||
| 01/11/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/04/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Immunology | ||||||
| 12/20/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Immunology | ||||||
| 12/14/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2022 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), DUOBRII, ARAZLO | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Podiatry | ||||||
| 12/06/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.04 | General |
| Category: Immunology | ||||||
| 11/18/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Dermatology | ||||||
| 11/16/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $77.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2022 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Immunology | ||||||
| 11/03/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Immunology | ||||||
| 10/25/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 445 | 731 | $88,893 | $11,099 |
| 2022 | 12 | 1,931 | 4,446 | $417,521 | $89,369 |
| 2021 | 14 | 2,001 | 4,828 | $408,169 | $86,683 |
| 2020 | 11 | 1,764 | 3,565 | $353,509 | $74,037 |
Total Patients
6,141
Total Services
13,570
Medicare Billing
$261,187
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 113 | $22,605 | $3,457 | 15.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 86 | 96 | $25,309 | $3,363 | 13.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 86 | 92 | $14,389 | $1,089 | 7.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 52 | 54 | $7,131 | $831.57 | 11.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 66 | 325 | $5,085 | $695.48 | 13.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 25 | 25 | $5,911 | $691.02 | 11.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 13 | $5,100 | $622.93 | 12.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,364 | $349.40 | 10.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 157 | 211 | $56,284 | $14,007 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 182 | 240 | $50,962 | $12,822 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 192 | 290 | $46,197 | $9,527 | 20.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2022 | 180 | 265 | $41,155 | $8,531 | 20.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 182 | 278 | $43,936 | $8,062 | 18.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 178 | 300 | $38,499 | $6,070 | 15.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 147 | 1,108 | $17,761 | $4,644 | 26.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 97 | 126 | $16,755 | $4,166 | 24.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 26 | 39 | $15,537 | $3,931 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 123 | 167 | $14,345 | $2,850 | 19.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $11,614 | $2,403 | 20.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 52 | 55 | $13,295 | $2,322 | 17.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 58 | 58 | $11,441 | $1,651 | 14.4% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 16 | 19 | $5,943 | $1,504 | 25.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2022 | 135 | 1,069 | $5,377 | $1,125 | 20.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 23 | 23 | $3,948 | $917.30 | 23.2% |
| 17111 | Destruction of skin growth, 15 or more growths | Facility | 2022 | 14 | 21 | $3,998 | $902.61 | 22.6% |
About Robin Westrum, ARNP
Robin Westrum, ARNP is a Nurse Practitioner healthcare provider based in Clive, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1265971329.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robin Westrum, ARNP has received a total of $1,530 in payments from pharmaceutical and medical device companies, with $49.10 received in 2024. These payments were reported across 73 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,276).
As a Medicare-enrolled provider, Westrum has provided services to 6,141 Medicare beneficiaries, totaling 13,570 services with total Medicare billing of $261,187. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Clive, IA
- Active Since 02/21/2017
- Last Updated 12/21/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1265971329
Products in Payments
- DUPIXENT (Biological) $399.86
- TALTZ (Drug) $142.76
- TREMFYA (Drug) $140.81
- Cimzia (Drug) $129.19
- SKYRIZI (Biological) $125.58
- RINVOQ (Biological) $100.79
- ILUMYA (Biological) $53.86
- Sotyktu (Drug) $40.92
- COSENTYX (Biological) $28.90
- PAXLOVID (Drug) $26.44
- REMICADE (Biological) $25.76
- Enbrel (Biological) $24.23
- JARDIANCE (Drug) $22.66
- Ilumya (Biological) $21.23
- OPZELURA (Drug) $18.13
- Winlevi (Drug) $17.90
- AMZEEQ (Drug) $17.01
- CIBINQO (Drug) $15.27
- JUBLIA (Drug) $11.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Clive
Taylor Whitt, Np, NP
Nurse Practitioner — Payments: $6,678
Nurse Practitioner $6,678
Christina Hendricks, Arnp, ARNP
Nurse Practitioner — Payments: $4,966
Nurse Practitioner $4,966
Cassie Mouw, Arnp, ARNP
Nurse Practitioner — Payments: $1,838
Nurse Practitioner $1,838
Corinne Conley, Arnp, ARNP
Nurse Practitioner — Payments: $1,660
Nurse Practitioner $1,660
Samantha Jensen, Arnp, ARNP
Nurse Practitioner — Payments: $1,471
Nurse Practitioner $1,471
Karen Luken, Np, NP
Nurse Practitioner — Payments: $1,066
Nurse Practitioner $1,066